» Articles » PMID: 37486750

DCABM-TCM: A Database of Constituents Absorbed into the Blood and Metabolites of Traditional Chinese Medicine

Abstract

Traditional Chinese medicine (TCM) not only maintains the health of Asian people but also provides a great resource of active natural products for modern drug development. Herein, we developed a Database of Constituents Absorbed into the Blood and Metabolites of TCM (DCABM-TCM), the first database systematically collecting blood constituents of TCM prescriptions and herbs, including prototypes and metabolites experimentally detected in the blood, together with the corresponding detailed detection conditions through manual literature mining. The DCABM-TCM has collected 1816 blood constituents with chemical structures of 192 prescriptions and 194 herbs and integrated their related annotations, including physicochemical, absorption, distribution, metabolism, excretion, and toxicity properties, and associated targets, pathways, and diseases. Furthermore, the DCABM-TCM supported two blood constituent-based analysis functions, the network pharmacology analysis for TCM molecular mechanism elucidation, and the target/pathway/disease-based screening of candidate blood constituents, herbs, or prescriptions for TCM-based drug discovery. The DCABM-TCM is freely accessible at http://bionet.ncpsb.org.cn/dcabm-tcm/. The DCABM-TCM will contribute to the elucidation of effective constituents and molecular mechanism of TCMs and the discovery of TCM-derived drug-like compounds that are both bioactive and bioavailable.

Citing Articles

Discovery of Isobavachin, a Natural Flavonoid, as an Apolipoprotein E4 (ApoE4) Structure Corrector for Alzheimer's Disease.

Patil S, Kuehn B, McCullough C, Bates D, Hazim H, Diallo M Molecules. 2025; 30(4).

PMID: 40005250 PMC: 11858207. DOI: 10.3390/molecules30040940.


Single-Cell Analysis Integrated With Machine Learning Elucidates the Mechanisms of Nucleus Pulposus Cells Apoptosis in Intervertebral Disc Degeneration and Therapeutic Interventions.

Song C, Wu X, Chen C, Shen B, Mei Y, Yan Q JOR Spine. 2025; 8(1):e70036.

PMID: 39835270 PMC: 11745822. DOI: 10.1002/jsp2.70036.


TarKG: a comprehensive biomedical knowledge graph for target discovery.

Zhou C, Cai C, Huang X, Wu S, Yu J, Wu J Bioinformatics. 2024; 40(10).

PMID: 39392404 PMC: 11513019. DOI: 10.1093/bioinformatics/btae598.


Metabolomics integrated with network pharmacology of blood-entry constituents reveals the bioactive component of Xuefu Zhuyu decoction and its angiogenic effects in treating traumatic brain injury.

Li T, Zhang L, Cheng M, Hu E, Yan Q, Wu Y Chin Med. 2024; 19(1):131.

PMID: 39327620 PMC: 11425933. DOI: 10.1186/s13020-024-01001-0.


Exploring the Molecular Mechanisms of Huaier on Modulating Metabolic Reprogramming of Hepatocellular Carcinoma: A Study based on Network Pharmacology, Molecular Docking and Bioinformatics.

Wan Y, Jiang H, Liu Z, Bai C, Lian Y, Zhang C Curr Pharm Des. 2024; 30(24):1894-1911.

PMID: 38747231 DOI: 10.2174/0113816128287535240429043610.


References
1.
Sun X, Zhang Y, Zhou Y, Lian X, Yan L, Pan T . NPCDR: natural product-based drug combination and its disease-specific molecular regulation. Nucleic Acids Res. 2021; 50(D1):D1324-D1333. PMC: 8728151. DOI: 10.1093/nar/gkab913. View

2.
Vivek-Ananth R, Mohanraj K, Sahoo A, Samal A . IMPPAT 2.0: An Enhanced and Expanded Phytochemical Atlas of Indian Medicinal Plants. ACS Omega. 2023; 8(9):8827-8845. PMC: 9996785. DOI: 10.1021/acsomega.3c00156. View

3.
Wang L, Zhou G, Liu P, Song J, Liang Y, Yan X . Dissection of mechanisms of Chinese medicinal formula Realgar-Indigo naturalis as an effective treatment for promyelocytic leukemia. Proc Natl Acad Sci U S A. 2008; 105(12):4826-31. PMC: 2290784. DOI: 10.1073/pnas.0712365105. View

4.
Xu H, Zhang Y, Liu Z, Chen T, Lv C, Tang S . ETCM: an encyclopaedia of traditional Chinese medicine. Nucleic Acids Res. 2018; 47(D1):D976-D982. PMC: 6323948. DOI: 10.1093/nar/gky987. View

5.
Wang Y, Zhang S, Li F, Zhou Y, Zhang Y, Wang Z . Therapeutic target database 2020: enriched resource for facilitating research and early development of targeted therapeutics. Nucleic Acids Res. 2019; 48(D1):D1031-D1041. PMC: 7145558. DOI: 10.1093/nar/gkz981. View